Survey on Real-World Interventions and Strategies for Treat-to-Target Approaches in Psoriasis Management in Canada - Takeaways - MDSpire

Survey on Real-World Interventions and Strategies for Treat-to-Target Approaches in Psoriasis Management in Canada

  • By

  • Jensen Yeung

  • Parbeer Grewal

  • Perla Lansang

  • Ron Vender

  • Marni Wiseman

  • Rami Abou Zeinab

  • Maxime Barakat

  • Vimal H. Prajapati

  • April 16, 2026

  • 0 min

Share

  • 1

    The study evaluated the application of Canadian treat-to-target criteria for moderate-to-severe plaque psoriasis in clinical practice.

  • 2

    Seventy-three percent of patients achieved treatment targets, with 98.4% of these patients continuing their biologic therapy.

  • 3

    Nearly half of the patients who did not meet treatment targets remained on therapy, influenced by Dermatology Life Quality Index and shared decision-making.

  • 4

    The findings highlight the clinical relevance of Canadian T2T criteria and the importance of individualized care and physician judgment.

  • 5

    The study underscores the need for structured assessment tools to guide treatment decisions and improve patient outcomes in psoriasis management.

Original Source(s)

Survey on Real-World Interventions and Strategies for Treat-to-Target Approaches in Psoriasis Management in Canada

  • by Jensen Yeung, Parbeer Grewal, Perla Lansang, Ron Vender, Marni Wiseman, Rami Abou Zeinab, Maxime Barakat, Vimal H. Prajapati

  • April 16, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Inhibition of TYK2 in Skin Autoimmune Disorders: Achieving Remission of Discoid Lupus and Psoriasis with Deucravacitinib and Complementary Confocal Microscopy Evidence

Efficacy of Upadacitinib in Managing Coexisting Psoriasis and Lichen Planus: A Case Study